New cancer clinical trial: Trial in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer

Published on: March 01, 2018 at 12:00PM
Condition:   Metastatic Urothelial Cancer
Interventions:   Drug: Nivolumab;   Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Oxaliplatin
Sponsors:   Matthew Galsky;   Bristol-Myers Squibb;   Hoosier Cancer Research Network
Not yet recruiting
http://ift.tt/2oCWBud